S-1 · resale registration
Issued 2026
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: OTC
DilutionScan read 34 of Vaxart, Inc.'s SEC filings and found 1 warrant series, 1 ATM program, 1 equity line, 2 shelf registrations, 1 S-1 registration and 2 completed offerings on file for VXRT. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Nov 1, 2026.
Raise routes on file: active ATM + effective shelf + effective S-1 + active equity line · latest dilution event 126 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Jun 30, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2026
Proposed maximum
Shares registered
Shares Underlying
Exercise Price
Issued 2025
Total capacity
Sold to date
Issued 2026
Commitment
Sold to date
Issued 2026
Total capacity
Remaining
Issued 2023
Total capacity
Remaining
Gross proceeds
Price per share
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z